NCT05616650 2026-04-16
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
32 trialsNCT05053152 2026-04-08
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
NRG Oncology
Phase 2 Active not recruiting
NCT05361798 2026-04-06
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT03436654 2026-03-27
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT07451795 2026-03-05
SHARP
Fudan University
Phase 2 Recruiting
NCT05320406 2026-02-12
REVELUTION
Emory University
Phase 2 Active not recruiting
NCT07393867 2026-02-06
ARPEGGIO
Brigham and Women's Hospital
Phase 2 Not yet recruiting
NCT03902951 2026-02-05
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT03796767 2026-01-28
SOAR
University of Utah
Phase 2 Active not recruiting
NCT06397703 2026-01-28
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
NYU Langone Health
Phase 2 Recruiting
NCT04402151 2026-01-26
PSMA SBRT-SIB
Weill Medical College of Cornell University
Phase 2 Recruiting
NCT05038332 2026-01-16
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
NCT06378866 2025-12-26
DIVINE
Mayo Clinic
Phase 2 Recruiting
NCT03007732 2025-12-05
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
University of California, San Francisco
Phase 2 Completed
NCT05893381 2025-12-03
LUST
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Recruiting
NCT07152067 2025-09-03
TOPPGUN-RS
Centre Hospitalier Universitaire de Liege
Phase 2 Not yet recruiting
NCT04915508 2025-06-22
EXCALIBUR
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
NCT05496959 2025-05-13
LUNAR
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT05169970 2025-05-08
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04262154 2025-04-27
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05655715 2024-10-16
CheckPRO
Herlev and Gentofte Hospital
Phase 2 Completed
NCT02680587 2022-11-29
ORIOLE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT05212857 2022-03-16
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Fudan University
Phase 2 Unknown
NCT03380806 2020-06-04
PBS
Juravinski Cancer Center
Phase 2 Unknown
NCT01439542 2018-08-09
FASTR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Terminated
NCT02313298 2018-03-29
Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer
National Cancer Centre, Singapore
Phase 2 Unknown
NCT03392233 2018-01-05
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
RenJi Hospital
Phase 2 Recruiting
NCT00851916 2017-07-21
CyberKnife Radiosurgery for Locally Recurrent Prostate CA
CyberKnife Centers of San Diego
Phase 2 Unknown
NCT01045148 2017-07-21
CyberKnife Radiosurgery for Localized Prostatic Carcinoma
CyberKnife Centers of San Diego
Phase 2 Unknown
NCT00587964 2016-02-22
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02344667 2015-01-26
Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT
Juravinski Cancer Center
Phase 2 Unknown
NCT02145494 2014-05-23
SPARC
Royal Marsden NHS Foundation Trust
Phase 2 Unknown